Biotech Values

[DewDiligence]

Synageva BioPharma acquires TRMS in reverse merger:

http://finance.yahoo.com/news/Synageva-BioPharma-and-bw-2868742718.html?x=0&.v=1

…upon completion of the merger, Trimeris will issue to Synageva stockholders shares of Trimeris common stock such that Synageva stockholders will own approximately 75% of the combined company's shares outstanding, and Trimeris stockholders will own approximately 25%.